GHSI
Guardion Health Sciences, Inc.
Set alert
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 3.25
- Prev close
- 3.25
- Mkt cap
- 4.35M
- Vol
- 664
- Avg vol
- 120.95K
- EPS
- -4.11
- P/E
- -0.79
- Div yield
- 174.67%
More statistics
- Low
- 3.25
- High
- 3.25
- Forward P/E
- -3.16
- Beta
- 0.71
- Short ratio
- 0.18
- Inst. own
- 21.09%
- Dividend
- 20.00
- Ex-div date
- Sep 23, 2024
- Earnings
- Aug 13, 2024
- 50-d avg
- 5.92
- 200-d avg
- 8.37
- 1y target
- 0.00
Key statistics
- Market cap
- 4.35M
- Enterprise value
- -10.69M
- Trailing P/E
- 0.00
- Forward P/E
- -3.16
- PEG ratio
- 0.00
- Price / sales
- 0.36
- Price / book
- 0.30
- EPS (TTM)
- -4.11
- Beta
- 0.71
- Dividend yield
- 174.67%
- Payout ratio
- 0.00%
- Profit margin
- 52.13%
- Revenue (TTM)
- 12.23M
- Revenue growth
- -8.40%
- Free cash flow
- 1.38M
- Total cash
- 14.82M
- Total debt
- 0
- Return on equity
- -50.26%
- Shares outstanding
- 1.35M
- Short % of float
- 2.56%
- 50-day average
- 5.92
- 200-day average
- 8.37
Analyst view
Consensus: buy
Next earnings
Aug 13, 2024
Expected Aug 13, 2024. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Mar 28, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 13, 2023 | Sep 1, 2023 | 0.00 | — | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
| May 15, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
About Guardion Health Sciences, Inc.
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- Country
- United States
- Website
- guardionhealth.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on GHSI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| RADOFF BRADLEY LOUIS | Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 25, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 2.95% | 37,620 | 292.68K | Jun 29, 2023 |
| Blackrock Inc. | 0.79% | 10,030 | 78.03K | Jun 29, 2023 |
| Barclays Plc | 0.07% | 900 | 7.00K | Jun 29, 2023 |
| Morgan Stanley | 0.05% | 659 | 5.13K | Jun 29, 2023 |
| Citigroup Inc. | 0.03% | 373 | 2.90K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.25% | 3,165 | 24.62K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.15% | 1,938 | 11.96K | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.04% | 527 | 3.25K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.03% | 375 | 2.31K | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.03% | 430 | 2.65K | May 30, 2023 |